HuGE Literature Finder
Records
1
-
30
| A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing. Cellular oncology (Dordrecht) 2021 Jun . Fan Fan, Zhang Hao, Dai Ziyu, Zhang Yakun, Xia Zhiwei, Cao Hui, Yang Kui, Hu Shui, Guo Yong, Ding Fengqin, Cheng Quan, Zhang N |
| BRAF more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAF but without a survival advantage. BMC neurology 2021 May 21 (1): 195. Wang Wei, Wang Maode, Jiang Haitao, Wang Tuo, Da Ro |
| High prevalence of clonal hematopoiesis-type genomic abnormalities in cell-free DNA in invasive gliomas after treatment. International journal of cancer 2021 Jan . Okamura Ryosuke, Piccioni David E, Boichard Amélie, Lee Suzanna, Jimenez Rebecca E, Sicklick Jason K, Kato Shumei, Kurzrock Razel |
| Clinical and Genomic Characteristics of Adult Diffuse Midline Glioma. Cancer research and treatment : official journal of Korean Cancer Association 2020 Nov . Park Changhee, Kim Tae Min, Bae Jeong Mo, Yun Hongseok, Kim Jin Wook, Choi Seung Hong, Lee Soon-Tae, Lee Joo Ho, Park Sung-Hye, Park Chul-K |
| A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas. Cancer science 2020 Aug . Higa Nayuta, Akahane Toshiaki, Yokoyama Seiya, Yonezawa Hajime, Uchida Hiroyuki, Takajo Tomoko, Kirishima Mari, Hamada Taiji, Matsuo Kei, Fujio Shingo, Hanada Tomoko, Hosoyama Hiroshi, Yonenaga Masanori, Sakamoto Akihisa, Hiraki Tsubasa, Tanimoto Akihide, Yoshimoto Ko |
| Germline cancer predisposition variants and pediatric glioma: a population-based study in California. Neuro-oncology 2020 Jan . Muskens Ivo S, de Smith Adam J, Zhang Chenan, Hansen Helen M, Morimoto Libby, Metayer Catherine, Ma Xiaomei, Walsh Kyle M, Wiemels Joseph |
| Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients. Frontiers in oncology 2020 10 607429. Li Hainan, Shan Changguo, Wu Shengnan, Cheng Baijie, Fan Chongzu, Cai Linbo, Chen Yedan, Shi Yuqian, Liu Kaihua, Shao Yang, Zhu Dan, Li Z |
| The Genetic Architecture of Gliomagenesis-Genetic Risk Variants Linked to Specific Molecular Subtypes. Cancers 2019 Dec 11 (12): . Wu Wendy Yi-Ying, Johansson Gunnar, Wibom Carl, Brännström Thomas, Malmström Annika, Henriksson Roger, Golovleva Irina, Bondy Melissa L, Andersson Ulrika, Dahlin Anna M, Melin Beatri |
| Genomic analysis of primary and recurrent gliomas reveals clinical outcome related molecular features. Scientific reports 2019 Nov 9 (1): 16058. Zhang Longbo, Liu Zhiqiang, Li Jin, Huang Tianxiang, Wang Ying, Chang Lianpeng, Zheng Wenjie, Ma Yujie, Chen Fenghua, Gong Xuan, Yuan Qianying, Teaw Shannon, Fang Xinqi, Song Tao, Huo Lei, Li Xi, Xia Xuefeng, Liu Zhixiong, Wu J |
| Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant. Nature communications 2019 Nov 10 (1): 5061. Deng Qipan, Hu Hui, Yu Xinfang, Liu Shuanglin, Wang Lei, Chen Weiqun, Zhang Chi, Zeng Zhaoyang, Cao Ya, Xu-Monette Zijun Y, Li Ling, Zhang Mingzhi, Rosenfeld Steven, Bao Shideng, Hsi Eric, Young Ken H, Lu Zhongxin, Li Yo |
| von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53. Brain tumor research and treatment 2019 Apr 7 (1): 33-38. Lehrer Steven, Rheinstein Peter H, Green Sheryl, Rosenzweig Kenneth |
| Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas. Journal of neurosurgery 2019 04 1-12. Ülgen Ege, Can Özge, Bilguvar Kaya, Oktay Yavuz, Akyerli Cemaliye B, Danyeli Ayça Ersen, Yakicier M Cengiz, Sezerman O Ugur, Pamir M Necmettin, Özduman Kor |
| Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
| Survival in males with glioma and gastric adenocarcinoma correlates with mutant p53 residual transcriptional activity. JCI insight 2018 Aug 3 (15): . Fischer Nicholas W, Prodeus Aaron, Gariépy Je |
| IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis. Cancer science 2018 May . Otani Ryohei, Uzuka Takeo, Higuchi Fumi, Matsuda Hadzki, Nomura Masashi, Tanaka Shota, Mukasa Akitake, Ichimura Koichi, Kim Phyo, Ueki Keisu |
| The clinicopathological and prognostic significance of TP53 alteration in K27M mutated gliomas: an individual-participant data meta-analysis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2018 Apr . Dong Chengya, Yuan Zhengrong, Li Qi, Wang Yaj |
| Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia (New York, N.Y.) 2018 Feb 20 (3): 256-262. Shajani-Yi Zahra, de Abreu Francine B, Peterson Jason D, Tsongalis Gregory |
| Blood-tissue analysis of TP53 polymorphisms and survival of patients with glioma. Journal of neurosurgical sciences 2018 Jan . Panciani Pier P, Giordana Maria T, Gallone Salvatore, Muratori Andrea, Rotunno Rosaria, Migliorati Karol, Spena Giannantonio, Ducati Alessandro, Fontanella Mar |
| Association Between Genetic Variant in the Promoter of Pri-miR-34b/c and Risk of Glioma. Frontiers in oncology 2018 8 413. Li Jinghui, Liu Xiaoyu, Qiao Yu, Qi Renli, Liu Shunjin, Guo Jing, Gui Yang, Li Juanjuan, Yu Hual |
| Racial Disparities in the Molecular Landscape of Cancer. Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
| Paradoxical prognostic impact of TERT promoter mutations in gliomas depends on different histological and genetic backgrounds. CNS neuroscience & therapeutics 2017 Oct 23 (10): 790-797. You Hao, Wu Yao, Chang Kai, Shi Xiao, Chen Xin-Da, Yan Wei, Li R |
| Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation. Neuro-oncology 2017 Aug . Kessler Tobias, Sahm Felix, Sadik Ahmed, Stichel Damian, Hertenstein Anne, Reifenberger Guido, Zacher Angela, Sabel Michael, Tabatabai Ghazaleh, Steinbach Joachim, Sure Ulrich, Krex Dietmar, Grosu Anca-L, Bewerunge-Hudler Melanie, Jones David, Pfister Stefan M, Weller Michael, Opitz Christiane, Bendszus Martin, von Deimling Andreas, Platten Michael, Wick Wolfga |
| Sexual dimorphism in glioma glycolysis underlies sex differences in survival. JCI insight 2017 Aug 2 (15): . Ippolito Joseph E, Yim Aldrin Kay-Yuen, Luo Jingqin, Chinnaiyan Prakash, Rubin Joshua |
| A novel TP53 variant (rs78378222 A > C) in the polyadenylation signal is associated with increased cancer susceptibility: evidence from a meta-analysis. Oncotarget 2016 May 7 (22): 32854-65. Wang Ying, Wu Xue-Song, He Jing, Ma Tianjiao, Lei Wei, Shen Zhen- |
| Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma. Journal of neuro-oncology 2016 May 127 (3): 483-92. Ghasimi Soma, Wibom Carl, Dahlin Anna M, Brännström Thomas, Golovleva Irina, Andersson Ulrika, Melin Beatri |
| Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma. The oncologist 2016 Feb . Fathi Amir T, Nahed Brian V, Wander Seth A, Iafrate A John, Borger Darrell R, Hu Ranliang, Thabet Ashraf, Cahill Daniel P, Perry Ashley M, Joseph Christelle P, Muzikansky Alona, Chi Andrew |
| IDH mutation is associated with higher risk of malignant transformation in low-grade glioma. Journal of neuro-oncology 2016 Jan . Leu Severina, von Felten Stefanie, Frank Stephan, Boulay Jean-Louis, Mariani Lui |
| Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics. Acta neuropathologica communications 2016 4 (1): 1. Hoffman Lindsey M, DeWire Mariko, Ryall Scott, Buczkowicz Pawel, Leach James, Miles Lili, Ramani Arun, Brudno Michael, Kumar Shiva Senthil, Drissi Rachid, Dexheimer Phillip, Salloum Ralph, Chow Lionel, Hummel Trent, Stevenson Charles, Lu Q Richard, Jones Blaise, Witte David, Aronow Bruce, Hawkins Cynthia E, Fouladi Mary |
| [Point mutations in the DNA binding domain of p53 contribute to glioma progression and poor prognosis]. Molekuliarnaia biologiia 0 51 (2): 334-341. Sarma P P, Dutta D, Mirza Z, Saikia K Kr, Baishya B |
| Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1. Neuro-oncology advances 0 2 (1): vdaa042. Alghamri Mahmoud S, Thalla Rohit, Avvari Ruthvik P, Dabaja Ali, Taher Ayman, Zhao Lili, Ulintz Peter J, Castro Maria G, Lowenstein Pedro |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: